Consumers, Health Practitioners Heeded FDA’s Call For WEN-Related AEs

FDA’s safety alert in July, asking WEN users and their doctors to share information regarding hair loss-related adverse events, yielded approximately 1,000 reports in just over two months, contributing to a massive increase in cosmetic AE reports for FY 2016.

More from Regulation

More from Policy & Regulation